Facebook
Twitter
LinkedIn
ForwardACHP-2020-Clinical-Biosimilars-Webinar 6-4-20
This is this second of three ACHP webinars that were originally planned as in-person programming for its Annual Spring Clinical Collaborative Meeting in Washington, DC on June 3-4, 2020. It is entitled: “Biosimilars: Making the Switch During a Pandemic,” on June 4, from 2:00 pm to 3:00 pm EST. How will the COVID-19 crisis and increased use of telehealth impact strategies to improve biosimilar uptake and utilization? Lingering barriers to biosimilar utilization in the U.S. include contract negotiations, patent litigation and uncertainty among patients and prescribers. This panel will discuss successful strategies to increase the adoption of biosimilars and address pharmacy costs in a post COVID-19 era.
Panelists include: Sameer Awsare, M.D., The Permanente Medical Group, Kevin Eichhorn, M.D., Dean Health Plan, Amy Gutierrez, Pharm.D., Kaiser Permanente, Moderator: Bobby Clark, HCM Strategists. In the weeks following the virtual Spring Clinical Conference, ACHP will be hosting additional webinars for clinical leaders on topics including: social needs, telehealth best practices, mental health access and parity, and innovations in drug supply chain, in the context of the post-COVID world.
Target Audience
Participants include ACHP Behavioral Health Directors, Pharmacy Directors, Quality Leaders, Medical Directors and Clinical Executives from ACHP member plans.
Learning Objectives
At the conclusion of this Biosimilar: Making the Switch During a Pandemic one-hour-long webinar:
Behavioral Health Leaders, Clinical and Quality Executives, Medical Directors, and Pharmacy Directors will be able to identify strategies to improve biosimilar uptake and utilization during the COVID-19 crisis and beyond; apply best practices for success in biosimilar utilization; and more thoroughly understand approaches to address pharmacy costs in a post COVID-19 era.
Additional Information
| Attachment | Size |
|---|---|
 ACHP-2020-Clinical-Biosimilars-Webinar-Handout_6-4-20 (002) APPROVED.pdf | 207.74 KB |
This is this second of three ACHP webinars that were originally planned as in-person programming for its Annual Spring Clinical Collaborative Meeting in Washington, DC on June 3-4, 2020. It is entitled: “Biosimilars: Making the Switch During a Pandemic,” on June 4, from 2:00 pm to 3:00 pm EST. How will the COVID-19 crisis and increased use of telehealth impact strategies to improve biosimilar uptake and utilization? Lingering barriers to biosimilar utilization in the U.S. include contract negotiations, patent litigation and uncertainty among patients and prescribers. This panel will discuss successful strategies to increase the adoption of biosimilars and address pharmacy costs in a post COVID-19 era.
Panelists include: Sameer Awsare, M.D., The Permanente Medical Group, Kevin Eichhorn, M.D., Dean Health Plan, Amy Gutierrez, Pharm.D., Kaiser Permanente, Moderator: Bobby Clark, HCM Strategists. In the weeks following the virtual Spring Clinical Conference, ACHP will be hosting additional webinars for clinical leaders on topics including: social needs, telehealth best practices, mental health access and parity, and innovations in drug supply chain, in the context of the post-COVID world.
Faculty Listing
Sameer Awsare, MD
Associate Executive Director
The Permanente Medical Group (TPMG)
Oakland, CA
Bobby Clark, MPP
Principal
HCM Strategists’ Health Innovation Team
Washington, DC
Kevin Eichhorn, MD
Chief Medical Officer
Dean Health Plan
Madison, WI
Amy Gutierrez, PharmD
Vice President, Digital Health Innovation
Senior Vice President and Chief Pharmacy Officer
Kaiser Permanente
Los Angeles, CA
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients to disclose.
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and the Alliance of Community Health Plans. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The University of Pittsburgh School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pharmacists
This knowledge-based activity provides 1.0 contact hour of continuing pharmacy education credit.
Nurses and Nurse Practitioners
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.
Other health care professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.00 Attendance